Director BENHAM DOUGLAS N bought 1,200 AMH shares at $24.20; cluster buy by 3 insiders in 14 days
Director BENHAM DOUGLAS N purchased 1,200 shares at $24.20 on 2026-03-02, increasing holdings to 44,717 shares. This buy occurred as part of a cluster pattern: 2 other insiders also bought within the past 14 days, signaling coordinated accumulation. At the same-ticker level, prior buys by this insider on 2024-12-05 and 2024-11-27 posted 90-day returns of +50.4% and +44.7% respectively, though a more recent buy on 2025-11-19 showed -0.5% over 90 days, indicating mixed timing outcomes at AMH. The current stock price of $30.03 reflects a -23.6% decline from the 52-week high, placing the purchase within a pullback context. Fundamental health remains solid with net income of $116,801,000.00 on revenue of $310,809,000.00, though the P/E of 25.45 and +3.4% annual revenue growth suggest moderate—not exceptional—financial momentum.